CL
ALBO

CSS LLC’s Albireo Pharma Inc ALBO Stock Holding History

CSS LLC’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,143
Closed -$251K – 1275
2022
Q2 		$241K Sell
12,143
-939
-7% -$24.8K 0.01% 774
2022
Q1 		$390K Buy
13,082
+2,500
+24% +$73.2K 0.01% 679
2021
Q4 		$246K Hold
10,582
– – 0.01% 866
2021
Q3 		$330K Buy
10,582
+2,308
+28% +$71.4K 0.01% 751
2021
Q2 		$291K Buy
8,274
+200
+2% +$6.5K 0.01% 770
2021
Q1 		$285K Buy
8,074
+1,500
+23% +$55.4K 0.01% 694
2020
Q4 		$247K Buy
+6,574
New +$239K 0.01% 600

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

CSS LLC's ALBO Position: Q3 2022 in Review

CSS LLC sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 12,143 shares — an estimated $251K sold.

CSS LLC first reported a position in ALBO in Q4 2020 and held it in 7 quarters. The position peaked at $390K in Q1 2022. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • CSS LLC reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • CSS LLC sold 12,143 Albireo Pharma Inc shares in Q3 2022, an estimated $251K.
  • CSS LLC first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 7 quarters.
  • CSS LLC's Albireo Pharma Inc position peaked at $390K in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.